Back to Search Start Over

Neisseria meningitidis Type IV Pili Composed of Sequence Invariable Pilins Are Masked by Multisite Glycosylation

Authors :
Joseph Gault
Mathias Ferber
Silke Machata
Anne-Flore Imhaus
Christian Malosse
Arthur Charles-Orszag
Corinne Millien
Guillaume Bouvier
Benjamin Bardiaux
Gérard Péhau-Arnaudet
Kelly Klinge
Isabelle Podglajen
Marie Cécile Ploy
H Steven Seifert
Michael Nilges
Julia Chamot-Rooke
Guillaume Duménil
Spectrométrie de Masse structurale et protéomique
Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)
Bioinformatique structurale - Structural Bioinformatics
Paris-Centre de Recherche Cardiovasculaire (PARCC - UMR-S U970)
Hôpital Européen Georges Pompidou [APHP] (HEGP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Feinberg School of Medicine, Northwestern University
Laboratoire de microbiologie
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)
Anti-infectieux : supports moléculaires des résistances et innovations thérapeutiques (RESINFIT)
CHU Limoges-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST)
Université de Limoges (UNILIM)-Université de Limoges (UNILIM)
This work was supported by: the Avenir INSERM Starting Grant (GD)
a CODDIM equipment grant (Région Ile de France, GD)
the Integrative Biology of Emerging Infectious Diseases (IBEID) laboratory of excellence (GD), the VIP European Research Council (ERC) starting grant (GD)
the Wellcome Trust grant WT093470AIA and NIH grant R37 AI033493 (HSS)
a Monge PhD scholarship at Ecole Polytechnique (JG)
and the European Union (FP7-IDEAS- ERC 294809) (MN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
European Project: 294809,EC:FP7:ERC,ERC-2011-ADG_20110310,BAYCELLS(2012)
UM, Maya
A Bayesian Framework for Cellular Structural Biology - BAYCELLS - - EC:FP7:ERC2012-05-01 - 2017-04-30 - 294809 - VALID
Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris]
Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST)
Université de Limoges (UNILIM)-Université de Limoges (UNILIM)-CHU Limoges
Source :
PLoS Pathogens, PLoS Pathogens, 2015, 11 (9), ⟨10.1371/journal.ppat.1005162⟩, PLoS Pathogens, Public Library of Science, 2015, 11 (9), ⟨10.1371/journal.ppat.1005162⟩, PLoS Pathogens, Vol 11, Iss 9, p e1005162 (2015)
Publication Year :
2015
Publisher :
HAL CCSD, 2015.

Abstract

The ability of pathogens to cause disease depends on their aptitude to escape the immune system. Type IV pili are extracellular filamentous virulence factors composed of pilin monomers and frequently expressed by bacterial pathogens. As such they are major targets for the host immune system. In the human pathogen Neisseria meningitidis, strains expressing class I pilins contain a genetic recombination system that promotes variation of the pilin sequence and is thought to aid immune escape. However, numerous hypervirulent clinical isolates express class II pilins that lack this property. This raises the question of how they evade immunity targeting type IV pili. As glycosylation is a possible source of antigenic variation it was investigated using top-down mass spectrometry to provide the highest molecular precision on the modified proteins. Unlike class I pilins that carry a single glycan, we found that class II pilins display up to 5 glycosylation sites per monomer on the pilus surface. Swapping of pilin class and genetic background shows that the pilin primary structure determines multisite glycosylation while the genetic background determines the nature of the glycans. Absence of glycosylation in class II pilins affects pilus biogenesis or enhances pilus-dependent aggregation in a strain specific fashion highlighting the extensive functional impact of multisite glycosylation. Finally, molecular modeling shows that glycans cover the surface of class II pilins and strongly decrease antibody access to the polypeptide chain. This strongly supports a model where strains expressing class II pilins evade the immune system by changing their sugar structure rather than pilin primary structure. Overall these results show that sequence invariable class II pilins are cloaked in glycans with extensive functional and immunological consequences.<br />Author Summary During infection pathogens and their host engage in a series of measures and counter-measures to promote their own survival: pathogens express virulence factors, the immune system targets these surface structures and pathogens modify them to evade detection. Like numerous bacterial pathogens, Neisseria meningitidis express type IV pili, long filamentous adhesive structures composed of pilins. Intriguingly the amino acid sequences of pilins from most hypervirulent strains do not vary, raising the question of how they evade the immune system. This study shows that the pilus structure is completely coated with sugars thus limiting access of antibodies to the pilin polypeptide chain. We propose that multisite glycosylation and thus variation in the type of sugar mediates immune evasion in these strains.

Details

Language :
English
ISSN :
15537366 and 15537374
Database :
OpenAIRE
Journal :
PLoS Pathogens, PLoS Pathogens, 2015, 11 (9), ⟨10.1371/journal.ppat.1005162⟩, PLoS Pathogens, Public Library of Science, 2015, 11 (9), ⟨10.1371/journal.ppat.1005162⟩, PLoS Pathogens, Vol 11, Iss 9, p e1005162 (2015)
Accession number :
edsair.pmid.dedup....2ac0a140e0e4d0995644ff5986f60769